Clever Culture Systems: Partnership
Clever Culture Systems (ASX: CC5) announced a partnership with CSL, a top-20 global pharmaceutical manufacturer, to evaluate APAS® Independence at CSL's Broadmeadows facility. This is the eighth major pharma company to adopt or evaluate the technology, representing $100M in upfront capital equipment and $10M recurring software revenue opportunities.
Source: Sharecafe AU markets
The leadership read
Strategic roles needed: VP/Director of Sales for pharma sector, Account Executives for major pharmaceutical manufacturers, Sales Engineers, Customer Success/Implementation managers to handle expansion with existing customers (FY27 focus shift), and potentially R&D roles for product enhancement based
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Oceania signal share is rising (+13.1pts).